Teva Neuroscience Inc. has a new drug to sell. Azilect, Teva Pharmaceutical Industries Ltd.'s tablet for the treatment of Parkinson's disease, has been approved by the U.S. Food and Drug Administration, the Israel-based drug maker said Wednesday.
Kansas City Business Journal